Characterization of the indole-3-glycerol phosphate synthase from Pseudomonas aeruginosa PAO1.

The Protein Journal
Monica L GerthWayne M Patrick

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen that causes chronic infections in the lungs of individuals with cystic fibrosis. It is intrinsically resistant to many antibiotics, and resistance is emerging rapidly to those drugs that currently remain efficacious. Therefore, there is a pressing need to identify new anti-pseudomonal drug targets. To this end, we have characterized the P. aeruginosa indole-3-glycerol phosphate synthase (PaIGPS). PaIGPS catalyzes the fifth reaction in the synthesis of tryptophan from chorismate--a reaction that is absent in mammals. PaIGPS was expressed heterologously in Escherichia coli, and purified with high yields. The purified enzyme is active over a broad pH range and has the highest turnover number of any characterized IGPS (k (cat) = 11.1 ± 0.1 s(-1)). These properties are likely to make PaIGPS useful in coupled assays for other enzymes in tryptophan biosynthesis. We have also shown that deleting the gene for PaIGPS reduces the fitness of P. aeruginosa strain PAO1 in synthetic cystic fibrosis sputum (relative fitness, W = 0.89 ± 0.02, P = 0.001). This suggests that de novo tryptophan biosynthesis may play a role in the establishment and maintenance of P. aeruginosa infections, and ther...Continue Reading

References

Feb 1, 1992·Molecular Microbiology·D M Gordon, M A Riley
Jan 1, 1989·Annual Review of Microbiology·I P Crawford
Dec 7, 1994·Journal of Theoretical Biology·E Klipp, R Heinrich
Nov 1, 1995·Protein Science : a Publication of the Protein Society·C N PaceT Gray
Feb 24, 2001·Environmental Microbiology·P B Rainey
Dec 14, 2001·The Journal of Biological Chemistry·Thorsten KnöchelKasper Kirschner
Aug 26, 2003·Antimicrobial Agents and Chemotherapy·Annika I NilssonDan I Andersson
Nov 21, 1960·Annals of the New York Academy of Sciences·E D GARBER
Jul 13, 2005·The FEBS Journal·Wayne M Patrick, Jonathan M Blackburn
Apr 28, 2006·Antimicrobial Agents and Chemotherapy·Yusuf NalcaSusanne Häussler
Apr 10, 2007·Current Opinion in Pharmacology·Marisa I Gómez, Alice Prince
Sep 18, 2007·Journal of Bacteriology·Kelli L PalmerMarvin Whiteley
Apr 1, 2008·Current Opinion in Microbiology·Enrique MerinoCharles Yanofsky
Aug 6, 2008·Nature Reviews. Microbiology·Stacie A BrownMarvin Whiteley
Feb 28, 2009·Nature Protocols·Lawrence A Kelley, Michael J E Sternberg
Apr 15, 2009·Archives of Biochemistry and Biophysics·Clarissa M CzeksterLuiz A Basso
Jun 30, 2009·Nature Chemical Biology·Bryson D BennettJoshua D Rabinowitz
Apr 9, 2011·Nature·Matthew A Cooper, David Shlaes
Jun 15, 2011·Trends in Microbiology·Elena B M BreidensteinRobert E W Hancock

❮ Previous
Next ❯

Citations

Feb 9, 2013·Bioscience, Biotechnology, and Biochemistry·Mayank SaraswatWayne M Patrick
Sep 29, 2018·Extremophiles : Life Under Extreme Conditions·Muhammad ArifMuhammad Akhtar
Aug 13, 2021·Chembiochem : a European Journal of Chemical Biology·Nikolas EspositoNina M Goodey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.